EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Tripartite Split‐GFP for High Throughput Screening of Small Molecules: A Powerful Strategy for Targeting Transient/Labile Interactors like E2‐E3 Ubiquitination Enzymes

Cécile Polge iD, Stéphanie Cabantous iD, Daniel Taillandier iD

ChemBioChem · 2024

DOI: 10.1002/cbic.202300723 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemBioChem, 2024. Verfasst von Cécile Polge und 2 weiteren Autor:innen. Beteiligte Einrichtung: Université Clermont Auvergne INRAE, UNH, Unité de Nutrition Humaine, F-63000, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Ubiquitin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Institut National de Recherche pour l'Agriculture, l'alimentation et l'Environnement, AFM/Telethon, French government IDEX-ISITE initiative 16-IDEX-0001.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for inhibitors of the Ubiquitin Proteasome System (UPS) is an expanding area, due to the crucial role of UPS enzymes in several diseases. The complexity of the UPS and the multiple protein‐protein interactions (PPIs) involved, either between UPS proteins themselves or between UPS components and theirs targets, offer an incredibly wide field for the development of chemical compounds for specifically modulating or inhibiting metabolic pathways. However, numerous UPS PPIs are transient/labile, due the processivity of the system (Ubiquitin [Ub] chain elongation, Ub transfer, etc.). Among the different strategies that can be used either for deciphering UPS PPI or for identifying/characterizing small compounds inhibitors, the split‐GFP approach offers several advantages notably for high throughput screening of drugs. Split‐GFP is based on the principle of protein‐fragment complementation assay (PCA). PCA allows addressing PPIs by coupling each protein of interest (POI) to fragments of a reporter protein whose reconstitution is linked to the interaction of the POI. Here, we review the evolution of the split‐GFP approach from bipartite to tripartite Split‐GFP and its recent applicability for screening chemical compounds targeting the UPS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Screening AssaysUbiquitinUbiquitinationUbiquitin-Protein LigasesProteinsProteasome Endopeptidase ComplexUbiquitin-Conjugating Enzymes

Stichwörter der Autor:innen

E2 ubiquitin-conjugating enzymeE3-ubiquitin ligaseHigh throughput screeningTripartite split-GFPUbiquitin Proteasome System

Substanzen

UbiquitinUbiquitin-Protein LigasesProteinsProteasome Endopeptidase ComplexUbiquitin-Conjugating Enzymes

Autor:innen und Institutionen

  • Université Clermont Auvergne INRAE, UNH, Unité de Nutrition Humaine, F-63000, Clermont-Ferrand, France.
  • Cancer Research Center of Toulouse INSERM UMR 1037, Université de Toulouse, F-31037, Toulouse, France.

ORCID-Profile: Cécile Polge, Stéphanie Cabantous, Daniel Taillandier

Förderung

  • Institut National de Recherche pour l'Agriculture, l'alimentation et l'Environnement
  • AFM/Telethon
  • French government IDEX-ISITE initiative 16-IDEX-0001
  • Fondation pour la Recherche Médicale
  • European Union's Horizon 2020 research and innovation program
  • Marie Skłodowska-Curie grant

Zitieren

APA

Polge, C., Cabantous, S., & Taillandier, D. (2024). Tripartite Split‐GFP for High Throughput Screening of Small Molecules: A Powerful Strategy for Targeting Transient/Labile Interactors like E2‐E3 Ubiquitination Enzymes. ChemBioChem. https://doi.org/10.1002/cbic.202300723

Vancouver

Polge C, Cabantous S, Taillandier D. Tripartite Split‐GFP for High Throughput Screening of Small Molecules: A Powerful Strategy for Targeting Transient/Labile Interactors like E2‐E3 Ubiquitination Enzymes. ChemBioChem. 2024. doi:10.1002/cbic.202300723

BibTeX
@article{Polge2024,
  author = {Polge, Cécile and Cabantous, Stéphanie and Taillandier, Daniel},
  title = {Tripartite Split‐GFP for High Throughput Screening of Small Molecules: A Powerful Strategy for Targeting Transient/Labile Interactors like E2‐E3 Ubiquitination Enzymes},
  journal = {ChemBioChem},
  year = {2024},
  doi = {10.1002/cbic.202300723}
}
Kostenlos starten →